The killer in our midst – fighting to end tuberculosis
Dr Helen McShane at the University of Oxford and the Oxford-Emergent Tuberculosis Consortium Ltd have received a Wellcome trust Strategic Award to part-fund the first trial to test efficacy of the new TB vaccine candidate, MVA85A, for potential efficacy in South African infants. In this film Dr McShane discusses the new vaccine candidate and these trials. www.wellcome.ac.uk
Related:
- Origin and spread of Mycobacterium tuberculosis
- Tuberculosis – is the white plague winning?
- Tuberculosis diagnostic tools
- Tuberculosis and the mystery of the missing genes
Tags: Africa, Bacteria, Biology, Health, Medicine, Microbiology, Science, Tuberculosis, Vaccines
